Trademark: 98043024
Word
CANTEX
Status
Pending
Status Code
641
Status Date
Tuesday, March 12, 2024
Serial Number
98043024
Mark Type
4000
Filing Date
Wednesday, June 14, 2023

Trademark Owner History

Classifications
5 Pharmaceuticals; Pharmaceutical preparations for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for inhibiting Receptor for Advanced Glycation End products (RAGE) interactions, for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for the treatment and prevention of diseases and disorders in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Pharmaceutical preparations for use in personalized medicine and targeted therapy
45 Licensing of pharmaceuticals and drug discovery technologies
44 Providing medical and scientific research information about the diagnosis and treatment of diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing information in the fields of health, wellness, and pharmaceuticals via a website
42 Pharmaceutical research and development; Development of new drugs for the prevention and treatment of cancer and other serious illnesses; Design and testing of new drugs and therapies; Medical and scientific research in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Medical and scientific research consulting in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Biological testing and research in the field of pharmaceuticals

Trademark Events
Mar 12, 2024
Notification Of Non-Final Action E-Mailed
Mar 12, 2024
Non-Final Action E-Mailed
Mar 12, 2024
Non-Final Action Written
Mar 4, 2024
Assigned To Examiner
Jul 18, 2023
New Application Office Supplied Data Entered
Jun 17, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24